Ayobami Olaniyi, MD

Scientific strategies| Drug R&D| Medicine & Global Health| Systems thinking. @boehringer
Previous stint with @rki_de @uchibadan_

Tweets are mine.

[Riinu Pius @_Riinu_]

🌟Day 15 – Understanding linear regression🌟

Real talk - first step to understanding logistic regression is understanding linear regression. So please have a 👀 and 🧠 even if your data needs log./Cox.

#HealthyR #rstats "R for Health Data Science" 📖:
https://t.co/bTtHk2WUVZ

[Ayobami Olaniyi, MD @phiyeen]

A solid professional career in my opinion is one that continually takes on progressively complex challenges that bedevil humanity!

[Ayobami Olaniyi, MD @phiyeen]

@yung_dee02 It's everywhere and it is worse in lower income countries. Major reason is that the germs becomes smarter the more we misuse antibiotics in humans, animals and agriculture - which we still do generally.

[Ayobami Olaniyi, MD @phiyeen]

#NewPublication #VRE
Germany’s Burden of Disease of Bloodstream Infections Due to Vancomycin-Resistant Enterococcus faecium between 2015–2020 https://t.co/iJRbRrygTv #

[Ayobami Olaniyi, MD @phiyeen]

@yung_dee02 Lol...damola how are you? Our study is laying out evidence that common place infections are becoming hard to treat because antibiotics are not working effectively like before. It's impt we use it responsibly: only if recommended.

[Ayobami Olaniyi, MD @phiyeen]

Congratulations Banji. More power!

[O.F @okeanaye]

They say the reward of hardwork, is more work.

I'm back!

[Ayobami Olaniyi, MD @phiyeen]

@countrybutions This is nice...it's a goal already...

[Ben See @ClimateBen]

BREAKING: horrific loss and damage as 50 million people are displaced by climate chaos in Pakistan 🧵

#LossAndDamage

[ScienceInsider @ScienceInsider]

BREAKING: White House issues new policy that will require, by 2026, all federally-funded research results to be freely available to public without delay, ending longstanding ability of journals to paywall results for up to 1 year. Coverage coming on @ScienceInsider.

[Ayobami Olaniyi, MD @phiyeen]

@DrAbioye @HIV_Medicine Congrats Jibola. Interesting points.

[World Health Organization (WHO) @WHO]

🚨 BREAKING:
"For all of these reasons, I have decided that the global #monkeypox outbreak represents a public health emergency of international concern."-@DrTedros

[Ayobami Olaniyi, MD @phiyeen]

When fully established, this should serve as a good practical case study for research ethics and integrity! It's comforting that the exposition is coming from within the neuroscience community! https://t.co/ehn2RNMR0w

[Ayobami Olaniyi, MD @phiyeen]

@DrAbioye The details of the alleged (but well corroborated) malfeasance at that level of research conduct is shocking to say the least.

[Ayobami Olaniyi, MD @phiyeen]

@countrybutions @yomisteve Lol...for the boys

[Ebuwa Alhaji @countrybutions]

Many don’t understand the negative impacts of exaggerating

It disqualifies you from future serious discussions. Because beyond the space in which you utter your embellished truths, your words become data points; and devoid of context, people see your data as nonsensical

[Ayobami Olaniyi, MD @phiyeen]

Many of the campaign for & against the Nigerian presidential candidates have been centered around religion & regional posturings. The discussions MUST be based on critical issues like quality 'non-ASUU strike' education, local goods production, gainful employment, security etc.

[Ayobami Olaniyi, MD @phiyeen]

Don't ever sell yourself short and watch out for learned helplessness!

[Boehringer Ingelheim @Boehringer]

Why do we care about the rise of antibiotic-resistant infections? “It threatens our ability to treat infections,” says Michel Pairet, Member of our Board of Managing Directors. How serious the situation is – and what he expects from our new joint venture “Aurobac”:

[Ayobami Olaniyi, MD @phiyeen]

I really find #rstat videos on LinkedIn learning easy and well put together.

[The Lancet Global Health @LancetGH]

The @WHO #cervicalcancer elimination plan faces challenges: a review and synthetic analysis finds that two in three women aged 30-49 years have never been screened for cervical cancer, with screening coverage particularly low in LMICs https://t.co/1AHwUKrffH